0000899243-18-020458.txt : 20180723
0000899243-18-020458.hdr.sgml : 20180723
20180723201559
ACCESSION NUMBER: 0000899243-18-020458
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180723
FILED AS OF DATE: 20180723
DATE AS OF CHANGE: 20180723
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REGENTS OF THE UNIVERSITY OF CALIFORNIA
CENTRAL INDEX KEY: 0000315054
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 18965448
BUSINESS ADDRESS:
STREET 1: 1111 BROADWAY
STREET 2: 21ST FLOOR
CITY: OAKLAND
STATE: CA
ZIP: 94607-4026
BUSINESS PHONE: 510-987-9600
MAIL ADDRESS:
STREET 1: 1111 BROADWAY
STREET 2: 21ST FLOOR
CITY: OAKLAND
STATE: CA
ZIP: 94607-4026
FORMER NAME:
FORMER CONFORMED NAME: REGENTS OF THE UNIVERSITY OF CA
DATE OF NAME CHANGE: 19600201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001434418
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-714-0555
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-23
1
0001434418
CONSTELLATION PHARMACEUTICALS INC
CNST
0000315054
REGENTS OF THE UNIVERSITY OF CALIFORNIA
1111 BROADWAY, SUITE 2100
OAKLAND
CA
94607
0
0
1
0
Common Stock
2018-07-23
4
C
0
2164073
A
2164073
D
Common Stock
2018-07-23
4
P
0
133333
15.00
A
2297406
D
Series E Preferred Stock
2018-07-23
4
C
0
6666666
0.00
D
Common Stock
778583
0
D
Series E-1 Preferred Stock
2018-07-23
4
C
0
6502856
0.00
D
Common Stock
590684
0
D
Series F Preferred Stock
2018-07-23
4
C
0
8750000
0.00
D
Common Stock
794806
0
D
On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
/s/ Arthur R. Guimaraes
2018-07-23